Evaluate the Performance of JOURNEY II CR in TKA Populations (JIICRTKA)

August 1, 2025 updated by: Smith & Nephew, Inc.

A Prospective Multi-Centre Study in Patients Undergoing Total Knee Replacement With JOURNEY II CR Total Knee System

Background:

The JOURNEY II CR Total Knee System consists of femoral component made from oxidized zirconium (OXINIUM)

Purpose:

Post-market evidence generation for JOURNEY II CR Total Knee System

Objectives:

Evaluate the performance of JOURNEY II CR TKA in APAC populations Evaluate the impact of patella resurfacing on the outcomes of JOURNEY II CR TKA

Research participants / locations:

A total of up to 480 knees' information will be collected in up to 15 sites in India, China mainland, Hong Kong, Singapore, Thailand and Japan There will be up to 240 knees for resurfaced patella group and up to 240 knees for un-resurfaced patella group.

Study Overview

Study Type

Observational

Enrollment (Actual)

62

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Beijing, China, 100083
        • Peking University Third Hospital
      • Hong Kong, China
        • Prince of Wales Hospital
    • Karnataka
      • Bengaluru, Karnataka, India, 560078
        • Aster RV Hospital, Bangalore
    • Maharashtra
      • Pune, Maharashtra, India, 411040
        • Arcus Hospital
      • Tokyo, Japan, 1628666
        • Tokyo Women's Medical University
      • Tokyo, Japan, 1438540
        • Toho University Omori Medical Center
      • Singapore, Singapore, 169608
        • Singapore General Hospital
      • Bangkok, Thailand, 10330
        • Chulalongkorn Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 80 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

A total of up to 480 knees' information will be collected in up to 15 sites in India, China mainland, Hong Kong, Singapore, Thailand and Japan There will be up to 240 knees for resurfaced patella group and up to 240 knees for un-resurfaced patella group.

Description

Inclusion Criteria:

  • Subjects with degenerative osteoarthritis.
  • Subject is planning to have TKA using JOURNEY II CR.
  • Subject is able and willing to provide voluntary consent to study participation.
  • Subject is 18-80 years old (inclusive) * (* For Japan, the minimum inclusion age is 20 years old.)

Exclusion Criteria:

  • Subjects with rheumatoid arthritis/inflammatory arthritis, posttraumatic arthritis.
  • Previous surgeries including HTO, UKA or TKA on the subject knee.
  • Subject is pregnant or breast feeding or those at a child-bearing age planning to become pregnant during the follow up.
  • Subject does not meet the indication or is contraindicated for JOURNEY II CR's IFU.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Resurfaced/non patella
Undergoing Total Knee Replacement with JOURNEY II CR Total Knee System
JOURNEY II CR Total Knee System was used for Total Knee replacement
un-resurfaced patella
Undergoing Total Knee Replacement with JOURNEY II CR Total Knee System
JOURNEY II CR Total Knee System was used for Total Knee replacement

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Oxford Knee Score (OKS) at 2 Years
Time Frame: 2 years
The Oxford Knee Score (OKS) is a Patient Reported Outcome questionnaire that was developed to specifically assess the patient's perspective of outcome following Total Knee Arthroplasty (TKA). The OKS is a patient self-completion PRO containing 12 equally weighted questions on activities of daily living. The OKS has been developed and validated specifically to assess perceived function and pain answered on a Likert scale after TKA. Responses to each question ranges from 0-4 with a range of a possible overall score from 0-48. A score of 0 is the worst possible outcome while a score of 48 is the best possible outcome.
2 years

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Forgotten Joint Score (FJS)
Time Frame: 6 months, 1 year, 2 years, 3 years
The Forgotten Joint Score (FJS) comprises measures for the assessment of joint-specific patient reported outcomes. This questionnaire focuses on the study participant's awareness of the partially or fully replaced knee joint in everyday life. Joint awareness can be simply defined as any unintended perception of a joint. Participants are asked to rate their awareness of their knee arthroplasty in 12 questions with a five-point Likert response format: "Never", "almost never", "seldom", "sometimes" and "mostly". The item scores are summed and linearly transformed in a 0 to 100 scale with a high value reflecting the ability of the subject to forget about the replaced knee joint during the activities of daily living (i.e., a higher score is a better outcome).
6 months, 1 year, 2 years, 3 years
Oxford Knee Score (OKS)
Time Frame: Pre-Operative, 6 months, 1 year, 3 years
The Oxford Knee Score (OKS) is a Patient Reported Outcome (PRO) questionnaire that was developed to specifically assess the patient's perspective of outcome following Total Knee Arthroplasty (TKA). The OKS is a patient self-completion PRO containing 12 equally weighted questions on activities of daily living. The OKS has been developed and validated specifically to assess perceived function and pain answered on a Likert scale after TKA. Overall scores range from 0 to 48, where a score of 0 is the worst possible outcome and a score of 48 is the best possible outcome.
Pre-Operative, 6 months, 1 year, 3 years
Knee Society Score (KSS): "Objective" Knee Score
Time Frame: Pre-Operative, 6 months, 1 year, 2 years, 3 years
The KSS is a validated tool that combines an objective physician-derived component with a subjective subject-derived component and consists of 4 separate sub-scales: The "Objective" Knee Score sub-scale is assessed by the surgeon, focusing on clinical measures such as pain, range of motion, and stability. The score is 7 items on a scale of 0 to 100 where a higher score indicates a better outcome.
Pre-Operative, 6 months, 1 year, 2 years, 3 years
Knee Society Score (KSS): Patient Satisfaction Score
Time Frame: Pre-Operative, 6 months, 1 year, 2 years, 3 years
The KSS is a validated tool that combines an objective physician-derived component with a subjective subject-derived component and consists of 4 separate sub-scales. The Patient Satisfaction sub-scale score evaluates the participant's satisfaction with their knee function and pain relief. The score is five items on a scale of 0 to 40 where a higher score indicates a better outcome.
Pre-Operative, 6 months, 1 year, 2 years, 3 years
Knee Society Score (KSS): Patient Expectation Score
Time Frame: Pre-Operative, 6 months, 1 year, 2 years, 3 years
The KSS is a validated tool that combines an objective physician-derived component with a subjective subject-derived component and consists of 4 separate sub-scales. The Patient Expectation sub-scale score assesses the participant's expectations regarding their knee function and outcomes. The score is three items on a scale of 3 to 15 where a higher score indicates a better outcome.
Pre-Operative, 6 months, 1 year, 2 years, 3 years
Knee Society Score (KSS): Functional Knee Score
Time Frame: Pre-Operative, 6 months, 1 year, 2 years, 3 years
The KSS is a validated tool that combines an objective physician-derived component with a subjective subject-derived component and consists of 4 separate sub-scales. The Functional Knee Score is derived from assessments of walking and standing, standard activities, advanced activities, and discretionary activities to evaluate the participant's ability to perform daily activities and their overall functional capabilities. The score is 19 items on a scale of 0 to 100 where a higher score indicates a better outcome.
Pre-Operative, 6 months, 1 year, 2 years, 3 years
Patient Expectation
Time Frame: Pre-Operative

Patient expectation measured by asking participants to select "ONE activity that matters to you most and you expect to participate after the surgery?" Responses were categorized as:

  1. Regularly participate in impact sports (e.g., jogging, tennis, skiing, acrobatics, ballet, heavy labor, backpacking, basketball, mountain climbing or badminton with running & jumping)
  2. Sometime participate in impact sports
  3. Regularly participate in very active events (e.g., bowling, golf, table tennis, badminton without running & jumping or fitness walking)
  4. Regularly participate in active events (e.g., bicycling or square dancing)
  5. Regularly participate in moderate activities (e.g., swimming & unlimited housework, shopping or Tai Chi)
  6. Sometimes participate in moderate activities
  7. Regularly participate in mild activities (e.g., walking, limited housework, & limited shopping)
  8. Sometimes participate in mild activities
  9. Restricted to minimal activities of daily living
  10. Missing
Pre-Operative
Patient Satisfaction
Time Frame: 6 months, 1 year, 2 years, 3 years

Patient satisfaction is measured by a corresponding question based on their expectation asking, "How satisfied are you with the surgery meeting your expectation?" Responses were categorized as:

  • Very Satisfied
  • Satisfied
  • Neutral
  • Dissatisfied
  • Very Dissatisfied
  • Missing
6 months, 1 year, 2 years, 3 years
Radiographic Assessment: Presence of Radiographic Findings
Time Frame: Immediate Post-op to 6 weeks, 6 months, 1 year, 2 years

Standard radiographic evaluation on antero-posterior (A/P) and lateral views performed to identify the number of participants with the presence of radiographic findings categorized as:

  • Yes
  • No
  • Missing
Immediate Post-op to 6 weeks, 6 months, 1 year, 2 years
Radiographic Assessment: Aseptic Loosening
Time Frame: Immediate Post-op to 6 weeks, 6 months, 1 year, 2 years

Standard radiographic evaluation on antero-posterior (A/P) and lateral views performed to identify the radiographic finding type by the presence of aseptic loosening as one of the following:

  • Yes
  • No
  • Missing
Immediate Post-op to 6 weeks, 6 months, 1 year, 2 years
Radiographic Assessment: Septic Loosening
Time Frame: Immediate Post-op to 6 weeks, 6 months, 1 year, 2 years

Standard radiographic evaluation on antero-posterior (A/P) and lateral views performed to identify the radiographic finding type by the presence of septic loosening as one of the following:

  • Yes
  • No
  • Missing
Immediate Post-op to 6 weeks, 6 months, 1 year, 2 years
Radiographic Assessment: Bone Fracture
Time Frame: Immediate Post-op to 6 weeks, 6 months, 1 year, 2 years

Standard radiographic evaluation on antero-posterior (A/P) and lateral views performed to identify the radiographic finding type by the presence of bone fracture as one of the following:

  • Yes
  • No
  • Missing
Immediate Post-op to 6 weeks, 6 months, 1 year, 2 years
Radiographic Assessment: Cement Fracture
Time Frame: Immediate Post-op to 6 weeks, 6 months, 1 year, 2 years

Standard radiographic evaluation on antero-posterior (A/P) and lateral views performed to identify the radiographic finding type by the presence of cement fracture as one of the following:

  • Yes
  • No
  • Missing
Immediate Post-op to 6 weeks, 6 months, 1 year, 2 years
Radiographic Assessment: Osteolysis
Time Frame: Immediate Post-op to 6 weeks, 6 months, 1 year, 2 years

Standard radiographic evaluation on antero-posterior (A/P) and lateral views performed to identify the radiographic finding type by the presence of osteolysis as one of the following:

  • Yes
  • No
  • Missing
Immediate Post-op to 6 weeks, 6 months, 1 year, 2 years
Radiographic Assessment: Subsidence
Time Frame: Immediate Post-op to 6 weeks, 6 months, 1 year, 2 years

Standard radiographic evaluation on antero-posterior (A/P) and lateral views performed to identify the radiographic finding type by the presence of subsidence as one of the following:

  • Yes
  • No
  • Missing
Immediate Post-op to 6 weeks, 6 months, 1 year, 2 years
Radiographic Assessment: Implant Migration
Time Frame: Immediate Post-op to 6 weeks, 6 months, 1 year, 2 years

Standard radiographic evaluation on antero-posterior (A/P) and lateral views performed to identify the radiographic finding type by the presence of implant migration as one of the following:

  • Yes
  • No
  • Missing
Immediate Post-op to 6 weeks, 6 months, 1 year, 2 years
Radiographic Assessment: Stress Shielding
Time Frame: Immediate Post-op to 6 weeks, 6 months, 1 year, 2 years

Standard radiographic evaluation on antero-posterior (A/P) and lateral views performed to identify the radiographic finding type by the presence of stress shielding as one of the following:

  • Yes
  • No
  • Missing
Immediate Post-op to 6 weeks, 6 months, 1 year, 2 years
Radiographic Assessment: Implant-Cement Debonding
Time Frame: Immediate Post-op to 6 weeks, 6 months, 1 year, 2 years

Standard radiographic evaluation on antero-posterior (A/P) and lateral views performed to identify the radiographic finding type by the presence of implant-cement debonding as one of the following:

  • Yes
  • No
  • Missing
Immediate Post-op to 6 weeks, 6 months, 1 year, 2 years
Radiographic Assessment: Mechanical Axis Alignment of the Knee Joint
Time Frame: Pre-Operative, 6 months, 1 year, 2 years
Standard radiographic evaluation on antero-posterior (A/P) and lateral views performed to determine mechanical axis alignment of the knee joint in degrees measured through the centre of the hip (centre of the spherical femoral head), centre of the knee (centre of the tibial plateau) and centre of the ankle (centre of the talus).
Pre-Operative, 6 months, 1 year, 2 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Julian Yang, Smith & Nephew, Inc.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 3, 2022

Primary Completion (Actual)

March 15, 2024

Study Completion (Actual)

March 15, 2024

Study Registration Dates

First Submitted

March 24, 2021

First Submitted That Met QC Criteria

March 24, 2021

First Posted (Actual)

March 26, 2021

Study Record Updates

Last Update Posted (Actual)

August 20, 2025

Last Update Submitted That Met QC Criteria

August 1, 2025

Last Verified

August 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • Journey II CR.2020.11

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Arthroplasty

Clinical Trials on Resurfaced Patella

Subscribe